Disease-free survival related factors in breast cancer

Davila-Arias, Cristina; Ocon, Olga; Fernandez, Mariana F.; Pedro Arrebola, Juan; Jose Sanchez, Maria; Aneiros, Jose; Torne, Pablo; Olea, Nicolas

Abstract

Objective: To evaluate the relationship between the clinical and pathological parameters of the primary tumor and disease-free survival (DFS) in a sample of hospital cases of invasive breast cancer. Material and method: We performed a retrospective cohort study in 635 patients recruited at San Cecilio University Hospital in Granada (Spain) between 1994 and 2006. Information on the primary tumor and the outcomes of patients was collected by reviewing the medical records. Predictors of recurrence and/or metastasis and DFS (follow up of 3, 5 and 10 years) were analyzed by using Cox regression analysis. Results: Multivariate models adjusted for age, tumor size, lymph nodal status, histological grade and estrogen and progesterone receptor expression showed a higher risk of recurrence and/or metastasis and lower DFS (adjusted relative risk, 95% confidence intervals) with tumor size (3 yrs: 3.00, 1.79-5.03; 5 yrs: 2.56, 1.65-3.98; 10 yrs: 2.16, 1.44-3.24), lymph nodal status (3 yrs: 4.58, 2.42-8.65; 5 yrs: 3.84, 2.35-6.30; 10 yrs: 3.08, 2.05-4.61), lymphovascular invasion (5 yrs: 1.88, 1.16-3.04; 10 yrs: 2.19, 1.43-3.35), multifocal and/or multicenter tumors (3 yrs: 2.69, 1.46-4.96; 5 yrs: 1.90, 1.08-3.35) and p53 protein expression (3 yrs: 2.03, 1.00-4.09). DFS was positively associated with an increased expression of progesterone receptor (3 yr: 0.48,0.26-0.89; 5 yrs: 0.58,035-0.97; 10 yrs: 0.59,0.38-0.90). Conclusions: The biological characteristics of the primary tumor can be used to identify patients with distinctive prognoses and DFS, and could be helpful in making individual follow up strategies. (C) 2013 Elsevier Espana, S.L.U. All rights reserved.

Más información

Título según WOS: ID WOS:000343069800002 Not found in local WOS DB
Título de la Revista: MEDICINA CLINICA
Volumen: 143
Número: 7
Editorial: ELSEVIER DOYMA SL
Fecha de publicación: 2014
Página de inicio: 293
Página final: 299
DOI:

10.1016/j.medcli.2013.09.041

Notas: ISI